Internal Medicine, Infectious Disease · New York, NY
NPI
1235110651
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
10 Union Sq E
New York, NY, 10003
Phone (212) 844-8549
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
155 services
Medicare patients, 2024
88
Average age 72
Drug cost, 2024
$2.1M
987 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David C Perlman was code 99214 (office e&m - established), 71 times for 44 patients. In total David C Perlman billed 155 services in 6 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 71 | 44 | $67.64 | $4,802 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 28 | $102.99 | $5,046 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $139.52 | $3,349 |
By year: 2022 $18K for 189 services; 2023 $14K for 140 services; 2024 $14K for 155 services.
Medicare prescription drug claims, 2024
In 2024, the drug David C Perlman prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 276 prescriptions and refills. In total David C Perlman wrote 987 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 276 | 292 | 33 | $1.2M |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 39 | 39 | Under 11 | $144K |
| Tivicay Dolutegravir Sodium | 38 | 60 | Under 11 | $126K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 31 | 35 | Under 11 | $137K |
| Zolpidem Tartrate Generic | 30 | 30 | Under 11 | $48.34 |
| Dovato Dolutegravir Sodium/Lamivudine | 27 | 29 | Under 11 | $85K |
| Etravirine Generic | 26 | 26 | Under 11 | $31K |
| Complera Emtricita/Rilpivirine/Tenof Df | 23 | 37 | Under 11 | $123K |
| Methenamine Hippurate Generic | 20 | 20 | Under 11 | $839 |
| Valacyclovir Valacyclovir Hcl | 20 | 30 | Under 11 | $781 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 18 | 20 | Under 11 | $20.51 |
| Azithromycin Generic | 16 | 16 | Under 11 | $65.85 |
| Isentress Raltegravir Potassium | 15 | 15 | Under 11 | $29K |
| Diazepam Generic | 15 | 15 | Under 11 | $75.97 |
| Doxepin Hcl Generic | 14 | 14 | Under 11 | $780 |
Brand drugs: 521 claims; generic drugs: - claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to David C Perlman were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.